Epigral Ltd — Profit & Loss Statement

₹810.45

-5.15%

Epigral Ltd Profit & Loss Statement (Annual)

Metric	2025	2024	2023	2022
Tax Effect Of Unusual Items	0.35 Cr	-1.10 Cr	0.72 Cr	0.34 Cr
Tax Rate For Calcs	0.34	0.33	0.32	0.34
Normalized EBITDA	715.15 Cr	480.02 Cr	678.98 Cr	500.24 Cr
Total Unusual Items	1.02 Cr	-3.38 Cr	2.23 Cr	0.99 Cr
Total Unusual Items Excluding Goodwill	1.02 Cr	-3.38 Cr	2.23 Cr	0.99 Cr
Net Income From Continuing Operation Net Minority Interest	357.69 Cr	195.87 Cr	353.29 Cr	252.79 Cr
Reconciled Depreciation	132.56 Cr	123.56 Cr	108.95 Cr	85.91 Cr
Reconciled Cost Of Revenue	1.41K Cr	1.12K Cr	1.17K Cr	801.33 Cr
EBITDA	716.17 Cr	476.64 Cr	681.20 Cr	501.23 Cr
EBIT	583.61 Cr	353.08 Cr	572.25 Cr	415.33 Cr
Net Interest Income	-46.67 Cr	-74.04 Cr	-49.43 Cr	-32.29 Cr
Interest Expense	42.52 Cr	62.33 Cr	49.79 Cr	31.91 Cr
Interest Income	0.33 Cr	0.10 Cr	0.84 Cr	0.16 Cr
Normalized Income	357.02 Cr	198.15 Cr	351.79 Cr	252.13 Cr
Net Income From Continuing And Discontinued Operation	357.69 Cr	195.87 Cr	353.29 Cr	252.79 Cr
Total Expenses	1.94K Cr	1.54K Cr	1.59K Cr	1.13K Cr
Rent Expense Supplemental	13.00 Cr	12.22 Cr	1.95 Cr	0.04 Cr
Diluted Average Shares	4.22 Cr	4.16 Cr	4.16 Cr	4.16 Cr
Basic Average Shares	4.22 Cr	4.16 Cr	4.16 Cr	4.16 Cr
Diluted EPS	84.68	47.14	85.03	60.84
Basic EPS	84.68	47.14	85.03	60.84
Diluted NI Availto Com Stockholders	357.69 Cr	195.87 Cr	353.29 Cr	252.79 Cr
Net Income Common Stockholders	357.69 Cr	195.87 Cr	353.29 Cr	252.79 Cr
Otherunder Preferred Stock Dividend	0.00	0.00	0.00	0.00
Net Income	357.69 Cr	195.87 Cr	353.29 Cr	252.79 Cr
Minority Interests	0.00	0.00	0.00	0.00
Net Income Including Noncontrolling Interests	357.69 Cr	195.87 Cr	353.29 Cr	252.79 Cr
Net Income Continuous Operations	357.69 Cr	195.87 Cr	353.29 Cr	252.79 Cr
Tax Provision	183.40 Cr	94.88 Cr	169.17 Cr	130.64 Cr
Pretax Income	541.09 Cr	290.75 Cr	522.46 Cr	383.42 Cr
Other Non Operating Income Expenses	0.34 Cr	1.60 Cr	3.06 Cr	0.99 Cr
Special Income Charges	5.04 Cr	-0.05 Cr	0.91 Cr	1.65 Cr
Other Special Charges	-5.04 Cr	0.05 Cr	-0.91 Cr	-1.65 Cr
Net Non Operating Interest Income Expense	-46.67 Cr	-74.04 Cr	-49.43 Cr	-32.29 Cr
Total Other Finance Cost	4.48 Cr	11.81 Cr	0.48 Cr	0.54 Cr
Interest Expense Non Operating	42.52 Cr	62.33 Cr	49.79 Cr	31.91 Cr
Interest Income Non Operating	0.33 Cr	0.10 Cr	0.84 Cr	0.16 Cr
Operating Income	578.16 Cr	357.69 Cr	580.00 Cr	423.78 Cr
Operating Expense	526.94 Cr	420.94 Cr	421.91 Cr	324.62 Cr
Other Operating Expenses	232.14 Cr	181.41 Cr	193.50 Cr	129.36 Cr
Depreciation And Amortization In Income Statement	132.56 Cr	123.56 Cr	108.95 Cr	85.91 Cr
Depreciation Income Statement	132.56 Cr	123.56 Cr	108.95 Cr	82.67 Cr
Research And Development	0.55 Cr	0.94 Cr	—	—
Selling General And Administration	50.14 Cr	32.66 Cr	35.63 Cr	21.73 Cr
Selling And Marketing Expense	45.13 Cr	25.66 Cr	29.36 Cr	17.02 Cr
General And Administrative Expense	5.01 Cr	7.00 Cr	6.27 Cr	4.71 Cr
Rent And Landing Fees	13.00 Cr	12.22 Cr	1.95 Cr	0.04 Cr
Gross Profit	1.11K Cr	778.63 Cr	1.00K Cr	748.40 Cr
Cost Of Revenue	1.41K Cr	1.12K Cr	1.17K Cr	801.33 Cr
Total Revenue	2.51K Cr	1.89K Cr	2.17K Cr	1.55K Cr
Operating Revenue	2.51K Cr	1.89K Cr	2.17K Cr	1.55K Cr
Amortization	—	—	3.23 Cr	3.23 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Epigral Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Specialty Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.